{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T14:33:13Z","timestamp":1790346793677,"version":"4.1.0"},"reference-count":191,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2023,4,7]],"date-time":"2023-04-07T00:00:00Z","timestamp":1680825600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,4,7]],"date-time":"2023-04-07T00:00:00Z","timestamp":1680825600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000049","name":"U.S. Department of Health & Human Services | NIH | National Institute on Aging","doi-asserted-by":"publisher","award":["R01AG061190"],"award-info":[{"award-number":["R01AG061190"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"U.S. Department of Health & Human Services | NIH | National Institute on Aging","doi-asserted-by":"publisher","award":["R01AG062509"],"award-info":[{"award-number":["R01AG062509"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"U.S. Department of Health & Human Services | NIH | National Institute on Aging","doi-asserted-by":"publisher","award":["R01AG041274"],"award-info":[{"award-number":["R01AG041274"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"name":"U.S. Department of Health & Human Services | NIH | National Institute on Aging"},{"name":"U.S. Department of Health & Human Services | NIH | National Institute on Aging"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Psychiatry"],"published-print":{"date-parts":[[2023,11]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Neuroinflammatory disorders preferentially impair the higher cognitive and executive functions of the prefrontal cortex (PFC). This includes such challenging disorders as delirium, perioperative neurocognitive disorder, and the sustained cognitive deficits from \u201clong-COVID\u201d or traumatic brain injury. There are no FDA-approved treatments for these symptoms; thus, understanding their etiology is important for generating therapeutic strategies. The current review describes the molecular rationale for why PFC circuits are especially vulnerable to inflammation, and how \u03b12A-adrenoceptor (\u03b12A-AR) actions throughout the nervous and immune systems can benefit the circuits in PFC needed for higher cognition. The layer III circuits in the dorsolateral PFC (dlPFC) that generate and sustain the mental representations needed for higher cognition have unusual neurotransmission and neuromodulation. They are wholly dependent on NMDAR neurotransmission, with little AMPAR contribution, and thus are especially vulnerable to kynurenic acid inflammatory signaling which blocks NMDAR. Layer III dlPFC spines also have unusual neuromodulation, with cAMP magnification of calcium signaling in spines, which opens nearby potassium channels to rapidly weaken connectivity and reduce neuronal firing. This process must be tightly regulated, e.g. by mGluR3 or \u03b12A-AR on spines, to prevent loss of firing. However, the production of GCPII inflammatory signaling reduces mGluR3 actions and markedly diminishes dlPFC network firing. Both basic and clinical studies show that \u03b12A-AR agonists such as guanfacine can restore dlPFC network firing and cognitive function, through direct actions in the dlPFC, but also by reducing the activity of stress-related circuits, e.g. in the locus coeruleus and amygdala, and by having anti-inflammatory actions in the immune system. This information is particularly timely, as guanfacine is currently the focus of large clinical trials for the treatment of delirium, and in open label studies for the treatment of cognitive deficits from long-COVID.<\/jats:p>","DOI":"10.1038\/s41380-023-02057-4","type":"journal-article","created":{"date-parts":[[2023,4,7]],"date-time":"2023-04-07T07:03:01Z","timestamp":1680850981000},"page":"4540-4552","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Scientific rationale for the use of \u03b12A-adrenoceptor agonists in treating neuroinflammatory cognitive disorders"],"prefix":"10.1038","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3420-1308","authenticated-orcid":false,"given":"Amy F. T.","family":"Arnsten","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yumiko","family":"Ishizawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongcong","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,4,7]]},"reference":[{"key":"2057_CR1","doi-asserted-by":"crossref","first-page":"748212","DOI":"10.1155\/2015\/748212","volume":"2015","author":"AM Kirova","year":"2015","unstructured":"Kirova AM, Bays RB, Lagalwar S. Working memory and executive function decline across normal aging, mild cognitive impairment, and Alzheimer\u2019s disease. Biomed Res Int. 2015;2015:748212.","journal-title":"Biomed Res Int"},{"key":"2057_CR2","doi-asserted-by":"crossref","first-page":"33","DOI":"10.3233\/NRE-2002-17407","volume":"17","author":"B McDonald","year":"2002","unstructured":"McDonald B, Flashman L, Saykin AJ. Executive dysfunction following traumatic brain injury: neural substrates and treatment strategies. NeuroRehabilitation. 2002;17:33\u201344.","journal-title":"NeuroRehabilitation"},{"key":"2057_CR3","first-page":"119","volume":"111","author":"I Rundshagen","year":"2014","unstructured":"Rundshagen I. Postoperative cognitive dysfunction. Dtsch Arztebl Int. 2014;111:119\u201325.","journal-title":"Dtsch Arztebl Int"},{"key":"2057_CR4","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1016\/j.neuron.2014.08.011","volume":"83","author":"SM Szczepanski","year":"2014","unstructured":"Szczepanski SM, Knight RT. Insights into human behavior from lesions to the prefrontal cortex. Neuron. 2014;83:1002\u201318.","journal-title":"Neuron"},{"key":"2057_CR5","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/s13365-021-00954-4","volume":"27","author":"J Hellmuth","year":"2021","unstructured":"Hellmuth J, Barnett TA, Asken BM, Kelly JD, Torres L, Stephens ML, et al. Persistent COVID-19-associated neurocognitive symptoms in non-hospitalized patients. J Neurovirol. 2021;27:191\u20135.","journal-title":"J Neurovirol"},{"key":"2057_CR6","doi-asserted-by":"crossref","first-page":"3684","DOI":"10.1038\/s41380-020-00973-3","volume":"26","author":"AFT Arnsten","year":"2021","unstructured":"Arnsten AFT, Datta D, Wang M. The Genie in the Bottle- Magnified calcium signaling in dorsolateral prefrontal cortex. Mol Psychiatry. 2021;26:3684\u20133700.","journal-title":"Mol Psychiatry"},{"key":"2057_CR7","doi-asserted-by":"crossref","first-page":"107327","DOI":"10.1016\/j.nlm.2020.107327","volume":"176","author":"AFT Arnsten","year":"2020","unstructured":"Arnsten AFT. Guanfacine\u2019s mechanism of action in treating prefrontal cortical disorders: Successful translation across species. Neurobiol Learn Mem. 2020;176:107327.","journal-title":"Neurobiol Learn Mem"},{"key":"2057_CR8","first-page":"1909","volume":"35","author":"M G\u00f6thert","year":"1985","unstructured":"G\u00f6thert M. Role of autoreceptors in the function of the peripheral and central nervous system. Arzneimittelforschung. 1985;35:1909\u201316.","journal-title":"Arzneimittelforschung"},{"key":"2057_CR9","doi-asserted-by":"crossref","unstructured":"Goldman-Rakic PS. Circuitry of the primate prefrontal cortex and the regulation of behavior by representational memory. In: Plum F, editor. Handbook of Physiology, The Nervous System, Higher Functions of the Brain, vol. V. Bethesda MD, USA: American Physiological Society, 1987, pp 373\u2013417.","DOI":"10.1002\/cphy.cp010509"},{"key":"2057_CR10","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1093\/cercor\/10.3.206","volume":"10","author":"D Ong\u00fcr","year":"2000","unstructured":"Ong\u00fcr D, Price JL. The organization of networks within the orbital and medial prefrontal cortex of rats, monkeys and humans. Cereb Cortex. 2000;10:206\u201319.","journal-title":"Cereb Cortex"},{"key":"2057_CR11","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.tins.2008.08.008","volume":"31","author":"SP Wise","year":"2008","unstructured":"Wise SP. Forward frontal fields: phylogeny and fundamental function. Trends Neurosci. 2008;31:599\u2013608.","journal-title":"Trends Neurosci"},{"key":"2057_CR12","doi-asserted-by":"crossref","first-page":"8306","DOI":"10.1523\/JNEUROSCI.0860-20.2020","volume":"40","author":"MK Joyce","year":"2020","unstructured":"Joyce MK, Garcia-Cabezas MA, John Y, Barbas H. Serial prefrontal pathways are positioned to balance cognition and emotion in primates. J Neurosci. 2020;40:8306\u201328.","journal-title":"J Neurosci"},{"key":"2057_CR13","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/0896-6273(95)90304-6","volume":"14","author":"P Goldman-Rakic","year":"1995","unstructured":"Goldman-Rakic P. Cellular Basis of Working Memory. Neuron. 1995;14:477\u201385.","journal-title":"Neuron"},{"key":"2057_CR14","doi-asserted-by":"crossref","unstructured":"Arnsten AFT, Cools R. Neuromodulation of prefrontal cortex cognitive function in primates: The powerful roles of monoamines and acetylcholine. Neuropsychopharmacology. 2022;47:309\u201328.","DOI":"10.1038\/s41386-021-01100-8"},{"key":"2057_CR15","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.tics.2011.02.001","volume":"15","author":"S Tsujimoto","year":"2011","unstructured":"Tsujimoto S, Genovesio A, Wise SP. Frontal pole cortex: encoding ends at the end of the endbrain. Trends Cogn Sci. 2011;15:169\u201376.","journal-title":"Trends Cogn Sci"},{"key":"2057_CR16","doi-asserted-by":"crossref","first-page":"790006","DOI":"10.3389\/fnhum.2022.790006","volume":"16","author":"GR Wylie","year":"2022","unstructured":"Wylie GR, Pra Sisto AJ, Genova HM, DeLuca J. Fatigue Across the Lifespan in Men and Women: State vs. Trait. Front Hum Neurosci. 2022;16:790006.","journal-title":"Front Hum Neurosci"},{"key":"2057_CR17","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1001\/archgenpsychiatry.2011.1539","volume":"69","author":"RL Aupperle","year":"2012","unstructured":"Aupperle RL, Allard CB, Grimes EM, Simmons AN, Flagan T, Behrooznia M, et al. Dorsolateral prefrontal cortex activation during emotional anticipation and neuropsychological performance in posttraumatic stress disorder. Arch Gen Psychiatry. 2012;69:360\u201371.","journal-title":"Arch Gen Psychiatry"},{"key":"2057_CR18","doi-asserted-by":"crossref","first-page":"8837","DOI":"10.1073\/pnas.1600965113","volume":"113","author":"R Sinha","year":"2016","unstructured":"Sinha R, Lacadie CM, Constable RT, Seo D. Dynamic neural activity during stress signals resilient coping. Proc Natl Acad Sci USA. 2016;113:8837\u201342.","journal-title":"Proc Natl Acad Sci USA"},{"key":"2057_CR19","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-019-09562-7","volume":"10","author":"SE Holmes","year":"2019","unstructured":"Holmes SE, Scheinost D, Finnema SJ, Naganawa M, Davis MT, DellaGioia N, et al. Lower synaptic density is associated with depression severity and network alterations. Nat Commun. 2019;10:1529.","journal-title":"Nat Commun"},{"key":"2057_CR20","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.neuroscience.2008.12.050","volume":"159","author":"MM Hoskison","year":"2009","unstructured":"Hoskison MM, Moore AN, Hu B, Orsi SA, Kobori N, Dash PK. Persistent working memory dysfunction following traumatic brain injury: evidence for a time-dependent mechanism. Neuroscience. 2009;159:483\u201391.","journal-title":"Neuroscience"},{"key":"2057_CR21","doi-asserted-by":"crossref","first-page":"e24648","DOI":"10.1371\/journal.pone.0024648","volume":"6","author":"PK Dash","year":"2011","unstructured":"Dash PK, Johnson D, Clark J, Orsi SA, Zhang M, Zhao J, et al. Involvement of the glycogen synthase kinase-3 signaling pathway in TBI pathology and neurocognitive outcome. PLoS One. 2011;6:e24648.","journal-title":"PLoS One"},{"key":"2057_CR22","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.neuroscience.2010.10.048","volume":"172","author":"N Kobori","year":"2011","unstructured":"Kobori N, Hu B, Dash PK. Altered adrenergic receptor signaling following traumatic brain injury contributes to working memory dysfunction. Neuroscience. 2011;172:293\u2013302.","journal-title":"Neuroscience"},{"key":"2057_CR23","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1089\/neu.2014.3487","volume":"32","author":"N Kobori","year":"2015","unstructured":"Kobori N, Moore AN, Dash PK. Altered regulation of protein kinase a activity in the medial prefrontal cortex of normal and brain-injured animals actively engaged in a working memory task. J Neurotrauma. 2015;32:139\u201348.","journal-title":"J Neurotrauma"},{"key":"2057_CR24","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1056\/NEJMra052321","volume":"354","author":"SK Inouye","year":"2006","unstructured":"Inouye SK. Delirium in Older Persons. N. Engl J Med. 2006;354:1157\u201365.","journal-title":"N. Engl J Med"},{"key":"2057_CR25","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1055\/s-2008-1064100","volume":"17","author":"M Ylvisaker","year":"1996","unstructured":"Ylvisaker M, Feeney TJ. Executive functions after traumatic brain injury: supported cognition and self-advocacy. Semin Speech Lang. 1996;17:217\u201332.","journal-title":"Semin Speech Lang"},{"key":"2057_CR26","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1080\/02699050310001617370","volume":"18","author":"TW McAllister","year":"2004","unstructured":"McAllister TW, Flashman LA, Sparling MB, Saykin AJ. Working memory deficits after traumatic brain injury: catecholaminergic mechanisms and prospects for treatment - a review. Brain Inj. 2004;18:331\u201350.","journal-title":"Brain Inj"},{"key":"2057_CR27","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.pediatrneurol.2005.02.002","volume":"33","author":"HS Levin","year":"2005","unstructured":"Levin HS, Hanten G. Executive functions after traumatic brain injury in children. Pediatr Neurol. 2005;33:79\u201393.","journal-title":"Pediatr Neurol"},{"key":"2057_CR28","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1111\/j.1600-0404.1992.tb04009.x","volume":"85","author":"N Bohnen","year":"1992","unstructured":"Bohnen N, Twijnstra A, Jolles J. Performance in the Stroop color word test in relationship to the persistence of symptoms following mild head injury. Acta Neurol Scand. 1992;85:116\u201321.","journal-title":"Acta Neurol Scand"},{"key":"2057_CR29","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1001\/jamapsychiatry.2018.4288","volume":"76","author":"MB Stein","year":"2019","unstructured":"Stein MB, Jain S, Giacino JT, Levin H, Dikmen S, Nelson LD, et al. Risk of Posttraumatic Stress Disorder and Major Depression in Civilian Patients After Mild Traumatic Brain Injury: A TRACK-TBI Study. JAMA Psychiatry. 2019;76:249\u201358.","journal-title":"JAMA Psychiatry"},{"key":"2057_CR30","doi-asserted-by":"crossref","first-page":"175909142097956","DOI":"10.1177\/1759091420979567","volume":"12","author":"A Fesharaki-Zadeh","year":"2020","unstructured":"Fesharaki-Zadeh A, Miyauchi JT, St Laurent-Arriot K, Tsirka SE, Bergold PJ. Increased Behavioral Deficits and Inflammation in a Mouse Model of Co-Morbid Traumatic Brain Injury and Post-Traumatic Stress Disorder. ASN Neuro. 2020;12:1759091420979567.","journal-title":"ASN Neuro"},{"key":"2057_CR31","first-page":"S460","volume":"3","author":"RA Stern","year":"2011","unstructured":"Stern RA, Riley DO, Daneshvar DH, Nowinski CJ, Cantu RC, McKee AC. Long-term consequences of repetitive brain trauma: chronic traumatic encephalopathy. PMR. 2011;3:S460\u2013467.","journal-title":"PMR"},{"key":"2057_CR32","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1093\/brain\/aws307","volume":"136","author":"AC McKee","year":"2013","unstructured":"McKee AC, Stein TD, Nowinski CJ, Stern RA, Daneshvar DH, Alvarez VE, et al. The spectrum of disease in chronic traumatic encephalopathy. Brain. 2013;136:43\u201364.","journal-title":"Brain"},{"key":"2057_CR33","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/S0140-6736(97)07382-0","volume":"351","author":"JT Moller","year":"1998","unstructured":"Moller JT, Cluitmans P, Rasmussen LS. ISPOCD investigators ISoP-OCD. Long-term postoperative cognitive dysfunction in the elderly ISPOCD1 study. Lancet. 1998;351:857\u201361.","journal-title":"Lancet"},{"key":"2057_CR34","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1038\/nrn.2016.128","volume":"17","author":"L Vutskits","year":"2016","unstructured":"Vutskits L, Xie Z. Lasting impact of general anaesthesia on the brain: mechanisms and relevance. Nat Rev Neurosci. 2016;17:705\u201317.","journal-title":"Nat Rev Neurosci"},{"key":"2057_CR35","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1097\/ALN.0b013e31819b5ba6","volume":"110","author":"NH Greene","year":"2009","unstructured":"Greene NH, Attix DK, Weldon BC, Smith PJ, McDonagh DL, Monk TG. Measures of executive function and depression identify patients at risk for postoperative delirium. Anesthesiology. 2009;110:788\u201395.","journal-title":"Anesthesiology"},{"key":"2057_CR36","doi-asserted-by":"crossref","first-page":"e59525","DOI":"10.7554\/eLife.59525","volume":"10","author":"GA Mashour","year":"2021","unstructured":"Mashour GA, Palanca BJ, Basner M, Li D, Wang W, Blain-Moraes S, et al. Recovery of consciousness and cognition after general anesthesia in humans. Elife. 2021;10:e59525.","journal-title":"Elife"},{"key":"2057_CR37","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1213\/ANE.0000000000005824","volume":"134","author":"MG Baxter","year":"2022","unstructured":"Baxter MG, Mincer JS, Brallier JW, Schwartz AB, Ahn H, Nir T, et al. Cognitive Recovery by Decade in Healthy 40- to 80-Year-Old Volunteers After Anesthesia Without Surgery. Anesth Analg. 2022;134:389\u201399.","journal-title":"Anesth Analg"},{"key":"2057_CR38","doi-asserted-by":"crossref","first-page":"83","DOI":"10.3233\/NRE-203135","volume":"47","author":"NNM Brownlee","year":"2020","unstructured":"Brownlee NNM, Wilson FC, Curran DB, Lyttle N, McCann JP. Neurocognitive outcomes in adults following cerebral hypoxia: A systematic literature review. NeuroRehabilitation. 2020;47:83\u201397.","journal-title":"NeuroRehabilitation"},{"key":"2057_CR39","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s11011-021-00796-3","volume":"37","author":"X Wang","year":"2022","unstructured":"Wang X, Cui L, Ji X. Cognitive impairment caused by hypoxia: from clinical evidences to molecular mechanisms. Metab Brain Dis. 2022;37:51\u201366.","journal-title":"Metab Brain Dis"},{"key":"2057_CR40","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.neuroscience.2013.09.023","volume":"254","author":"H Kauser","year":"2013","unstructured":"Kauser H, Sahu S, Kumar S, Panjwani U. Guanfacine is an effective countermeasure for hypobaric hypoxia-induced cognitive decline. Neuroscience. 2013;254:110\u20139.","journal-title":"Neuroscience"},{"key":"2057_CR41","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1097\/YCO.0000000000000713","volume":"4","author":"WM Vanderlind","year":"2021","unstructured":"Vanderlind WM, Rabinovitz BB, Miao IY, Oberlin LE, Bueno-Castellano C, Fridman C, et al. A systematic review of neuropsychological and psychiatric sequalae of COVID-19: implications for treatment. Curr Opin Psychiatry. 2021;4:420\u201333.","journal-title":"Curr Opin Psychiatry"},{"key":"2057_CR42","doi-asserted-by":"crossref","first-page":"e2130645","DOI":"10.1001\/jamanetworkopen.2021.30645","volume":"4","author":"JH Becker","year":"2021","unstructured":"Becker JH, Lin JJ, Doernberg M, Stone K, Navis A, Festa JR, et al. Assessment of Cognitive Function in Patients After COVID-19 Infection. JAMA Netw Open. 2021;4:e2130645.","journal-title":"JAMA Netw Open"},{"key":"2057_CR43","doi-asserted-by":"crossref","first-page":"101044","DOI":"10.1016\/j.eclinm.2021.101044","volume":"39","author":"A Hampshire","year":"2021","unstructured":"Hampshire A, Trender W, Chamberlain SR, Jolly AE, Grant JE, Patrick F, et al. Cognitive deficits in people who have recovered from COVID-19. EClinicalMedicine. 2021;39:101044.","journal-title":"EClinicalMedicine"},{"key":"2057_CR44","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1097\/ALN.0000000000001378","volume":"125","author":"CJ Hayhurst","year":"2016","unstructured":"Hayhurst CJ, Pandharipande PP, Hughes CG. Intensive Care Unit Delirium: A Review of Diagnosis, Prevention, and Treatment. Anesthesiology. 2016;125:1229\u201341.","journal-title":"Anesthesiology"},{"key":"2057_CR45","doi-asserted-by":"crossref","first-page":"644317","DOI":"10.3389\/fneur.2021.644317","volume":"12","author":"C Carrarini","year":"2021","unstructured":"Carrarini C, Russo M, Dono F, Barbone F, Rispoli MG, Ferri L, et al. Agitation and Dementia: Prevention and Treatment Strategies in Acute and Chronic Conditions. Front Neurol. 2021;12:644317.","journal-title":"Front Neurol"},{"key":"2057_CR46","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1038\/nature10243","volume":"476","author":"M Wang","year":"2011","unstructured":"Wang M, Gamo NJ, Yang Y, Jin LE, Wang XJ, Laubach M, et al. Neuronal basis of age-related working memory decline. Nature. 2011;476:210\u20133.","journal-title":"Nature"},{"key":"2057_CR47","doi-asserted-by":"crossref","DOI":"10.1186\/s12974-019-1683-1","volume":"17","author":"D Datta","year":"2020","unstructured":"Datta D, Leslie SN, Morozov YM, Duque A, Rakic P, van Dyck CH, et al. Classical complement cascade initiating C1q protein within neurons in the aged rhesus macaque dorsolateral prefrontal cortex. J Neuroinflammation. 2020;17:8.","journal-title":"J Neuroinflammation"},{"key":"2057_CR48","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1016\/j.neuron.2012.12.032","volume":"77","author":"M Wang","year":"2013","unstructured":"Wang M, Yang Y, Wang CJ, Gamo NJ, Jin LE, Mazer JA, et al. NMDA receptors subserve working memory persistent neuronal firing In dorsolateral prefrontal cortex. Neuron. 2013;77:736\u201349.","journal-title":"Neuron"},{"key":"2057_CR49","doi-asserted-by":"crossref","first-page":"12078","DOI":"10.1073\/pnas.1307849110","volume":"110","author":"Y Yang","year":"2013","unstructured":"Yang Y, Paspalas CD, Jin LE, Picciotto MR, Arnsten AFT, Wang M. Nicotinic \u03b17 receptors enhance NMDA cognitive circuits in dorsolateral prefrontal cortex. Proc Nat Acad Sci USA. 2013;110:12078\u201383.","journal-title":"Proc Nat Acad Sci USA"},{"key":"2057_CR50","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/0896-6273(95)90046-2","volume":"15","author":"JT Isaac","year":"1995","unstructured":"Isaac JT, Nicoll RA, Malenka RC. Evidence for silent synapses: implications for the expression of LTP. Neuron. 1995;15:427\u201334.","journal-title":"Neuron"},{"key":"2057_CR51","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1093\/cercor\/bhx357","volume":"28","author":"ST Yang","year":"2018","unstructured":"Yang ST, Wang M, Paspalas CP, Crimins JL, Altman MT, Mazer JA, et al. Core differences in synaptic signaling between primary visual and dorsolateral prefrontal cortex. Cereb Cortex. 2018;28:1458\u201371.","journal-title":"Cereb Cortex"},{"key":"2057_CR52","doi-asserted-by":"crossref","first-page":"12018","DOI":"10.1523\/JNEUROSCI.1510-12.2012","volume":"32","author":"K Skoblenick","year":"2012","unstructured":"Skoblenick K, Everling S. NMDA antagonist ketamine reduces task selectivity in macaque dorsolateral prefrontal neurons and impairs performance of randomly interleaved prosaccades and antisaccades. J Neurosci. 2012;32:12018\u201327.","journal-title":"J Neurosci"},{"key":"2057_CR53","doi-asserted-by":"crossref","first-page":"2613","DOI":"10.1038\/npp.2013.170","volume":"38","author":"NR Driesen","year":"2013","unstructured":"Driesen NR, McCarthy G, Bhagwagar Z, Bloch MH, Calhoun VD, D\u2019Souza DC, et al. The impact of NMDA receptor blockade on human working memory-related prefrontal function and connectivity. Neuropsychopharmacology. 2013;38:2613\u201322.","journal-title":"Neuropsychopharmacology"},{"key":"2057_CR54","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1038\/nn.2971","volume":"14","author":"PL Croxson","year":"2011","unstructured":"Croxson PL, Kyriazis DA, Baxter MG. Cholinergic modulation of a specific memory function of prefrontal cortex. Nat Neurosci. 2011;14:1510\u20132.","journal-title":"Nat Neurosci"},{"key":"2057_CR55","first-page":"7","volume":"6","author":"CK Lim","year":"2013","unstructured":"Lim CK, Yap MM, Kent SJ, Gras G, Samah B, Batten JC, et al. Characterization of the kynurenine pathway and quinolinic Acid production in macaque macrophages. Int J Tryptophan Res. 2013;6:7\u201319.","journal-title":"Int J Tryptophan Res"},{"key":"2057_CR56","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.psyneuen.2018.04.019","volume":"94","author":"AM Garrison","year":"2018","unstructured":"Garrison AM, Parrott JM, Tu\u00f1on A, Delgado J, Redus L, O\u2019Connor JC. Kynurenine pathway metabolic balance influences microglia activity: Targeting kynurenine monooxygenase to dampen neuroinflammation. Psychoneuroendocrinology. 2018;94:1\u201310.","journal-title":"Psychoneuroendocrinology"},{"key":"2057_CR57","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/s41380-019-0414-4","volume":"25","author":"J Savitz","year":"2020","unstructured":"Savitz J. The kynurenine pathway: a finger in every pie. Mol Psychiatry. 2020;25:131\u201347.","journal-title":"Mol Psychiatry"},{"key":"2057_CR58","doi-asserted-by":"crossref","first-page":"2007","DOI":"10.1111\/j.1471-4159.1991.tb03460.x","volume":"56","author":"S Fukui","year":"1991","unstructured":"Fukui S, Schwarcz R, Rapoport SI, Takada Y, Smith QR. Blood-brain barrier transport of kynurenines: implications for brain synthesis and metabolism. J Neurochem. 1991;56:2007\u201317.","journal-title":"J Neurochem"},{"key":"2057_CR59","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/nrn3257","volume":"13","author":"R Schwarcz","year":"2012","unstructured":"Schwarcz R, Bruno JP, Muchowski PJ, Wu HQ. Kynurenines in the mammalian brain: when physiology meets pathology. Nat Rev Neurosci. 2012;13:465\u201377.","journal-title":"Nat Rev Neurosci"},{"key":"2057_CR60","doi-asserted-by":"crossref","first-page":"10592","DOI":"10.1523\/JNEUROSCI.1107-14.2014","volume":"34","author":"R Kozak","year":"2014","unstructured":"Kozak R, Campbell BM, Strick CA, Horner W, Hoffmann WE, Kiss T, et al. Reduction of brain kynurenic acid improves cognitive function. J Neurosci. 2014;34:10592\u2013602.","journal-title":"J Neurosci"},{"key":"2057_CR61","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1159\/000086295","volume":"14","author":"B Kepplinger","year":"2005","unstructured":"Kepplinger B, Baran H, Kainz A, Ferraz-Leite H, Newcombe J, Kalina P. Age-related increase of kynurenic acid in human cerebrospinal fluid - IgG and beta2-microglobulin changes. Neurosignals. 2005;14:126\u201335.","journal-title":"Neurosignals"},{"key":"2057_CR62","doi-asserted-by":"crossref","first-page":"e140327","DOI":"10.1172\/jci.insight.140327","volume":"5","author":"T Thomas","year":"2020","unstructured":"Thomas T, Stefanoni D, Reisz JA, Nemkov T, Bertolone L, Francis RO, et al. COVID-19 infection alters kynurenine and fatty acid metabolism, correlating with IL-6 levels and renal status. JCI Insight. 2020;5:e140327.","journal-title":"JCI Insight"},{"key":"2057_CR63","doi-asserted-by":"crossref","first-page":"eabf8483","DOI":"10.1126\/scisignal.abf8483","volume":"14","author":"Y Cai","year":"2021","unstructured":"Cai Y, Kim DJ, Takahashi T, Broadhurst DI, Yan H, Ma S, et al. Kynurenic acid may underlie sex-specific immune responses to COVID-19. Sci Signal. 2021;14:eabf8483.","journal-title":"Sci Signal"},{"key":"2057_CR64","doi-asserted-by":"crossref","first-page":"2796","DOI":"10.1021\/acs.jproteome.1c00052","volume":"20","author":"NG Lawler","year":"2021","unstructured":"Lawler NG, Gray N, Kimhofer T, Boughton B, Gay M, Yang R, et al. Systemic Perturbations in Amine and Kynurenine Metabolism Associated with Acute SARS-CoV-2 Infection and Inflammatory Cytokine Responses. J Proteome Res. 2021;20:2796\u20132711.","journal-title":"J Proteome Res"},{"key":"2057_CR65","doi-asserted-by":"publisher","unstructured":"Cysique LA, Jakabek D, Bracken SG, Allen-Davidian Y, Heng B, Chow S, et al. Post-acute COVID-19 cognitive impairment and decline uniquely associate with kynurenine pathway activation: a longitudinal observational study. medRxiv. 2022. https:\/\/doi.org\/10.1101\/2022.06.07.22276020.","DOI":"10.1101\/2022.06.07.22276020"},{"key":"2057_CR66","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1002\/alz.12558","volume":"18","author":"S Reiken","year":"2022","unstructured":"Reiken S, Sittenfeld L, Dridi H, Liu Y, Liu X, Marks AR. Alzheimer\u2019s-like signaling in brains of COVID-19 patients. Alzheimers Dement. 2022;18:955\u201365.","journal-title":"Alzheimers Dement"},{"key":"2057_CR67","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1097\/CCM.0b013e318236f62d","volume":"40","author":"JR Adams Wilson","year":"2012","unstructured":"Adams Wilson JR, Morandi A, Girard TD, Thompson JL, Boomershine CS, Shintani AK, et al. The association of the kynurenine pathway of tryptophan metabolism with acute brain dysfunction during critical illness. Crit Care Med. 2012;40:835\u201341.","journal-title":"Crit Care Med"},{"key":"2057_CR68","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1111\/j.1471-4159.2011.07414.x","volume":"119","author":"CM Forrest","year":"2011","unstructured":"Forrest CM, Mackay GM, Oxford L, Millar K, Darlington LG, Higgins MJ, et al. Kynurenine metabolism predicts cognitive function in patients following cardiac bypass and thoracic surgery. J Neurochem. 2011;119:136\u201352.","journal-title":"J Neurochem"},{"key":"2057_CR69","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.biopsych.2021.05.021","volume":"91","author":"TB Meier","year":"2022","unstructured":"Meier TB, Savitz J. The Kynurenine Pathway in Traumatic Brain Injury: Implications for Psychiatric Outcomes. Biol Psychiatry. 2022;91:449\u201358.","journal-title":"Biol Psychiatry"},{"key":"2057_CR70","volume":"12","author":"EB Yan","year":"2015","unstructured":"Yan EB, Frugier T, Lim CK, Heng B, Sundaram G, Tan M, et al. Activation of the kynurenine pathway and increased production of the excitotoxin quinolinic acid following traumatic brain injury in humans. J Neuroinflammation. 2015;12:110.","journal-title":"J Neuroinflammation"},{"key":"2057_CR71","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.cell.2007.03.015","volume":"129","author":"M Wang","year":"2007","unstructured":"Wang M, Ramos B, Paspalas C, Shu Y, Simen A, Duque A, et al. Alpha2A-adrenoceptor stimulation strengthens working memory networks by inhibiting cAMP-HCN channel signaling in prefrontal cortex. Cell. 2007;129:397\u2013410.","journal-title":"Cell"},{"key":"2057_CR72","doi-asserted-by":"crossref","unstructured":"Wu J, El-Hassar L, Datta D, Thomas M, Zhang Y, David PJ, et al. Interaction Between HCN and Slack Channels Regulates mPFC Pyramidal Cell Excitability and Working Memory. bioRxiv. 2023. https:\/\/www.biorxiv.org\/content\/10.1101\/2023.03.04.529157v1.","DOI":"10.1101\/2023.03.04.529157"},{"key":"2057_CR73","doi-asserted-by":"crossref","first-page":"100187","DOI":"10.1016\/j.ynstr.2019.100187","volume":"11","author":"AFT Arnsten","year":"2019","unstructured":"Arnsten AFT, Jin LE, Gamo NJ, Ramos B, Paspalas CD, Morozov Y, et al. Role of KCNQ potassium channels in stress-induced deficit of working memory. Neurobio Stress. 2019;11:100187.","journal-title":"Neurobio Stress"},{"key":"2057_CR74","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/j.neuron.2020.02.030","volume":"106","author":"VC Galvin","year":"2020","unstructured":"Galvin VC, Yang S-T, Paspalas CD, Yang Y, Jin LE, Datta D, et al. Muscarinic M1 receptors modulate working memory performance and activity via KCNQ potassium channels in primate prefrontal cortex. Neuron. 2020;106:649\u201361.","journal-title":"Neuron"},{"key":"2057_CR75","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/S0092-8674(00)81904-2","volume":"88","author":"T Abel","year":"1997","unstructured":"Abel T, Nguyen PV, Barad M, Deuel TA, Kandel ER, Bourtchouladze R. Genetic demonstration of a role for PKA in the late phase of LTP and in hippocampus-based long-term memory. Cell. 1997;88:615\u201326.","journal-title":"Cell"},{"key":"2057_CR76","doi-asserted-by":"crossref","first-page":"8936","DOI":"10.1523\/JNEUROSCI.0248-16.2016","volume":"36","author":"R Havekes","year":"2016","unstructured":"Havekes R, Park AJ, Tolentino RE, Bruinenberg VM, Tudor JC, Lee Y, et al. Compartmentalized PDE4A5 Signaling Impairs Hippocampal Synaptic Plasticity and Long-Term Memory. J Neurosci. 2016;36:8936\u201346.","journal-title":"J Neurosci"},{"key":"2057_CR77","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.neuron.2012.08.038","volume":"76","author":"AFT Arnsten","year":"2012","unstructured":"Arnsten AFT, Wang M, Paspalas CD. Neuromodulation of thought: Flexibilities and vulnerabilities in prefrontal cortical network synapses. Neuron. 2012;76:223\u201339.","journal-title":"Neuron"},{"key":"2057_CR78","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1038\/nrn2648","volume":"10","author":"AFT Arnsten","year":"2009","unstructured":"Arnsten AFT. Stress signaling pathways that impair prefrontal cortex structure and function. Nat Rev Neurosci. 2009;10:410\u201322.","journal-title":"Nat Rev Neurosci"},{"key":"2057_CR79","doi-asserted-by":"crossref","first-page":"113","DOI":"10.3390\/brainsci9050113","volume":"9","author":"D Datta","year":"2019","unstructured":"Datta D, Arnsten AFT. Loss of Prefrontal Cortical Higher Cognition with Uncontrollable Stress: Molecular Mechanisms, Changes with Age, and Relevance to Treatment. Brain Sci. 2019;9:113.","journal-title":"Brain Sci"},{"key":"2057_CR80","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/0306-4522(94)00331-X","volume":"64","author":"JM Finlay","year":"1995","unstructured":"Finlay JM, Zigmond MJ, Abercrombie ED. Increased dopamine and norepinephrine release in medial prefrontal cortex induced by acute and chronic stress: effects of diazepam. Neuroscience. 1995;64:619\u201328.","journal-title":"Neuroscience"},{"key":"2057_CR81","doi-asserted-by":"crossref","first-page":"4787","DOI":"10.1523\/JNEUROSCI.16-15-04787.1996","volume":"16","author":"LE Goldstein","year":"1996","unstructured":"Goldstein LE, Rasmusson AM, Bunney SB, Roth RH. Role of the amygdala in the coordination of behavioral, neuroendocrine and prefrontal cortical monoamine responses to psychological stress in the rat. J Neurosci. 1996;16:4787\u201398.","journal-title":"J Neurosci"},{"key":"2057_CR82","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1089\/neu.2006.23.1094","volume":"23","author":"N Kobori","year":"2006","unstructured":"Kobori N, Clifton GL, Dash PK. Enhanced catecholamine synthesis in the prefrontal cortex after traumatic brain injury: implications for prefrontal dysfunction. J Neurotrauma. 2006;23:1094\u2013102.","journal-title":"J Neurotrauma"},{"key":"2057_CR83","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1126\/science.1100021","volume":"306","author":"SB Birnbaum","year":"2004","unstructured":"Birnbaum SB, Yuan P, Wang M, Vijayraghavan S, Bloom A, Davis D, et al. Protein kinase C overactivity impairs prefrontal cortical regulation of working memory. Science. 2004;306:882\u20134.","journal-title":"Science"},{"key":"2057_CR84","doi-asserted-by":"crossref","first-page":"2722","DOI":"10.1523\/JNEUROSCI.2472-18.2019","volume":"39","author":"D Datta","year":"2019","unstructured":"Datta D, Yang ST, Galvin VC, Solder J, Luo F, Morozov YM, et al. Noradrenergic \u03b11-Adrenoceptor Actions in the Primate Dorsolateral Prefrontal Cortex. J Neurosci. 2019;39:2722\u201334.","journal-title":"J Neurosci"},{"key":"2057_CR85","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1093\/cercor\/bhx005","volume":"28","author":"LE Jin","year":"2018","unstructured":"Jin LE, Wang M, Galvin VC, Lightbourne TC, Conn PJ, Arnsten AFT, et al. mGluR2 vs. mGluR3 in Primate Prefrontal Cortex: Postsynaptic mGluR3 Strengthen Cognitive Networks. Cereb Cortex. 2018;28:974\u201387.","journal-title":"Cereb Cortex"},{"key":"2057_CR86","doi-asserted-by":"crossref","unstructured":"Yang S, Datta D, Woo E, Duque A, Morozov YM, Arellano J, et al. Inhibition of glutamate-carboxypeptidase-II in dorsolateral prefrontal cortex: potential therapeutic target for neuroinflammatory cognitive disorders. Mol Psychiatry. 2022:27:4252\u201363.","DOI":"10.1038\/s41380-022-01656-x"},{"key":"2057_CR87","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1155\/NP.2000.133","volume":"7","author":"AFT Arnsten","year":"2000","unstructured":"Arnsten AFT. Through the looking glass: Differential noradrenergic modulation of prefrontal cortical function. Neural Plasticity. 2000;7:133\u201346.","journal-title":"Neural Plasticity"},{"key":"2057_CR88","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1002\/alz.12325","volume":"17","author":"D Datta","year":"2021","unstructured":"Datta D, Leslie S, Wang M, Yang S-T, Morozov Y, Mentone S, et al. Age-related calcium dysregulation linked with tau pathology and impaired cognition in non-human primates. Alzheimer\u2019s Dement. 2021;17:920\u201332.","journal-title":"Alzheimer\u2019s Dement"},{"key":"2057_CR89","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1002\/alz.12192","volume":"17","author":"AFT Arnsten","year":"2021","unstructured":"Arnsten AFT, Datta D, Del Tredici K, Braak H. Hypothesis: Tau Pathology is an Initiating Factor In Sporadic Alzheimer\u2019s Disease. Alzheimer\u2019s Dement. 2021;17:115\u201324.","journal-title":"Alzheimer\u2019s Dement"},{"key":"2057_CR90","doi-asserted-by":"crossref","first-page":"247054702110292","DOI":"10.1177\/24705470211029254","volume":"5","author":"E Woo","year":"2021","unstructured":"Woo E, Sansing LH, Arnsten AFT, Datta D. Chronic Stress Weakens Connectivity in the Prefrontal Cortex: Architectural and Molecular Changes. Chronic Stress. 2021;5:24705470211029254.","journal-title":"Chronic Stress"},{"key":"2057_CR91","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.nbd.2016.06.010","volume":"94","author":"Z Zhang","year":"2016","unstructured":"Zhang Z, Bassam B, Thomas AG, Williams M, Liu J, Nance E, et al. Maternal inflammation leads to impaired glutamate homeostasis and up-regulation of glutamate carboxypeptidase II in activated microglia in the fetal\/newborn rabbit brain. Neurobiol Dis. 2016;94:116\u201328.","journal-title":"Neurobiol Dis"},{"key":"2057_CR92","doi-asserted-by":"crossref","first-page":"126","DOI":"10.7150\/ntno.63158","volume":"6","author":"KR Hollinger","year":"2022","unstructured":"Hollinger KR, Sharma A, Tallon C, Lovell L, Thomas AG, Zhu X, et al. Dendrimer-2PMPA selectively blocks upregulated microglial GCPII activity and improves cognition in a mouse model of multiple sclerosis. Nanotheranostics. 2022;6:126\u201342.","journal-title":"Nanotheranostics"},{"key":"2057_CR93","doi-asserted-by":"crossref","first-page":"5036","DOI":"10.1073\/pnas.1322360111","volume":"111","author":"BC Carlyle","year":"2014","unstructured":"Carlyle BC, Nairn AC, Wang M, Yang Y, Jin LE, Simen AA, et al. cAMP-PKA phosphorylation of tau confers risk for degeneration in aging association cortex. Proc Natl Acad Sci USA. 2014;111:5036\u201341.","journal-title":"Proc Natl Acad Sci USA"},{"key":"2057_CR94","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1042\/BJ20101184","volume":"435","author":"KF MacKenzie","year":"2011","unstructured":"MacKenzie KF, Wallace DA, Hill EV, Anthony DF, Henderson DJ, Houslay DM, et al. Phosphorylation of cAMP-specific PDE4A5 (phosphodiesterase-4A5) by MK2 (MAPKAPK2) attenuates its activation through protein kinase A phosphorylation. Biochem J. 2011;435:755\u201369.","journal-title":"Biochem J"},{"key":"2057_CR95","doi-asserted-by":"crossref","first-page":"3227","DOI":"10.1073\/pnas.95.6.3227","volume":"95","author":"Q Guo","year":"1998","unstructured":"Guo Q, Christakos S, Robinson N, Mattson MP. Calbindin D28k blocks the proapoptotic actions of mutant presenilin 1: reduced oxidative stress and preserved mitochondrial function. Proc Natl Acad Sci USA. 1998;95:3227\u201332.","journal-title":"Proc Natl Acad Sci USA"},{"key":"2057_CR96","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/j.celrep.2017.10.006","volume":"21","author":"JT Li","year":"2017","unstructured":"Li JT, Xie XM, Yu JY, Sun YX, Liao XM, Wang XX, et al. Suppressed Calbindin Levels in Hippocampal Excitatory Neurons Mediate Stress-Induced Memory Loss. Cell Rep. 2017;21:891\u2013900.","journal-title":"Cell Rep"},{"key":"2057_CR97","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.biopsych.2004.10.034","volume":"57","author":"L Erraji-Benchekroun","year":"2005","unstructured":"Erraji-Benchekroun L, Underwood MD, Arango V, Galfalvy H, Pavlidis P, Smyrniotopoulos P, et al. Molecular aging in human prefrontal cortex is selective and continuous throughout adult life. Biol Psychiatry. 2005;57:549\u201358.","journal-title":"Biol Psychiatry"},{"key":"2057_CR98","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/0014-4886(91)90096-U","volume":"111","author":"PR Hof","year":"1991","unstructured":"Hof PR, Morrison JH. Neocortical neuronal subpopulations labeled by a monoclonal antibody to calbindin exhibit differential vulnerability in Alzheimer\u2019s disease. Exp Neurol. 1991;111:293\u2013301.","journal-title":"Exp Neurol"},{"key":"2057_CR99","doi-asserted-by":"crossref","unstructured":"Arnsten AFT, Woo E, Yang S, Wang M, Datta D. Unusual Molecular Regulation of Dorsolateral Prefrontal Cortex Layer III Synapses Increases Vulnerability to Genetic and Environmental Insults in Schizophrenia. Biol Psychiatry. 2022.","DOI":"10.1016\/j.biopsych.2022.02.003"},{"key":"2057_CR100","doi-asserted-by":"crossref","first-page":"30","DOI":"10.2174\/156720509787313934","volume":"6","author":"H Wei","year":"2009","unstructured":"Wei H, Xie Z. Anesthesia, calcium homeostasis and Alzheimer\u2019s disease. Curr Alzheimer Res. 2009;6:30\u201335.","journal-title":"Curr Alzheimer Res"},{"key":"2057_CR101","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1097\/ALN.0000000000000278","volume":"121","author":"G Tao","year":"2014","unstructured":"Tao G, Zhang J, Zhang L, Dong Y, Yu B, Crosby G, et al. Sevoflurane induces tau phosphorylation and glycogen synthase kinase 3\u03b2 activation in young mice. Anesthesiology. 2014;121:510\u201327.","journal-title":"Anesthesiology"},{"key":"2057_CR102","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1186\/s12871-019-0903-7","volume":"19","author":"JC Belrose","year":"2019","unstructured":"Belrose JC, Noppens RR. Anesthesiology and cognitive impairment: a narrative review of current clinical literature. BMC Anesthesiol. 2019;19:241.","journal-title":"BMC Anesthesiol"},{"key":"2057_CR103","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1038\/s42003-021-02047-8","volume":"4","author":"Y Dong","year":"2021","unstructured":"Dong Y, Liang F, Huang L, Fang F, Yang G, Tanzi RE, et al. The anesthetic sevoflurane induces tau trafficking from neurons to microglia. Commun Biol. 2021;4:560.","journal-title":"Commun Biol"},{"key":"2057_CR104","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1089\/neu.2016.4898","volume":"35","author":"J Zhao","year":"2018","unstructured":"Zhao J, Huynh J, Hylin MJ, O\u2019Malley JJ, Perez A, Moore AN, et al. Mild Traumatic Brain Injury Reduces Spine Density of Projection Neurons in the Medial Prefrontal Cortex and Impairs Extinction of Contextual Fear Memory. J Neurotrauma. 2018;35:149\u201356.","journal-title":"J Neurotrauma"},{"key":"2057_CR105","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.brainres.2016.01.053","volume":"1636","author":"H Kauser","year":"2016","unstructured":"Kauser H, Sahu S, Panjwani U. Guanfacine promotes neuronal survival in medial prefrontal cortex under hypobaric hypoxia. Brain Res. 2016;1636:152\u201360.","journal-title":"Brain Res"},{"key":"2057_CR106","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1016\/j.jstrokecerebrovasdis.2015.10.035","volume":"25","author":"W Zhang","year":"2016","unstructured":"Zhang W, Zhang Z, Wu L, Qiu Y, Lin Y. Suppression of Glutamate Carboxypeptidase II Ameliorates Neuronal Apoptosis from Ischemic Brain Injury. J Stroke Cerebrovasc Dis. 2016;25:1599\u2013605.","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"2057_CR107","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1111\/j.1471-4159.2006.03786.x","volume":"97","author":"C Zhong","year":"2006","unstructured":"Zhong C, Zhao X, Van KC, Bzdega T, Smyth A, Zhou J, et al. NAAG peptidase inhibitor increases dialysate NAAG and reduces glutamate, aspartate and GABA levels in the dorsal hippocampus following fluid percussion injury in the rat. J Neurochem. 2006;97:1015\u201325.","journal-title":"J Neurochem"},{"key":"2057_CR108","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1016\/j.neuroscience.2006.10.022","volume":"144","author":"P S\u00e1cha","year":"2007","unstructured":"S\u00e1cha P, Z\u00e1mecn\u00edk J, Barinka C, Hlouchov\u00e1 K, V\u00edcha A, Mlcochov\u00e1 P, et al. Expression of glutamate carboxypeptidase II in human brain. Neuroscience. 2007;144:1361\u201372.","journal-title":"Neuroscience"},{"key":"2057_CR109","doi-asserted-by":"crossref","first-page":"20101","DOI":"10.1073\/pnas.1209934109","volume":"109","author":"KA Rahn","year":"2012","unstructured":"Rahn KA, Watkins CC, Alt J, Rais R, Stathis M, Grishkan I, et al. Inhibition of glutamate carboxypeptidase II (GCPII) activity as a treatment for cognitive impairment in multiple sclerosis. Proc Natl Acad Sci USA. 2012;109:20101\u20136.","journal-title":"Proc Natl Acad Sci USA"},{"key":"2057_CR110","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1111\/jnc.13123","volume":"134","author":"Y Cao","year":"2015","unstructured":"Cao Y, Gao Y, Xu S, Cui Z, Zhang M, Lin Y, et al. Mice lacking glutamate carboxypeptidase II develop normally, but are less susceptible to traumatic brain injury. J Neurochem. 2015;134:340\u201353.","journal-title":"J Neurochem"},{"key":"2057_CR111","volume":"17","author":"Y Cao","year":"2016","unstructured":"Cao Y, Gao Y, Xu S, Bao J, Lin Y, Luo X, et al. Glutamate carboxypeptidase II gene knockout attenuates oxidative stress and cortical apoptosis after traumatic brain injury. BMC Neurosci. 2016;17:15.","journal-title":"BMC Neurosci"},{"key":"2057_CR112","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.nlm.2019.01.006","volume":"158","author":"JH Neale","year":"2019","unstructured":"Neale JH, Olszewski R. A role for N-acetylaspartylglutamate (NAAG) and mGluR3 in cognition. Neurobiol Learn Mem. 2019;158:9\u201313.","journal-title":"Neurobiol Learn Mem"},{"key":"2057_CR113","doi-asserted-by":"crossref","first-page":"101722","DOI":"10.1016\/j.pneurobio.2019.101722","volume":"184","author":"JH Neale","year":"2020","unstructured":"Neale JH, Yamamoto T. N-acetylaspartylglutamate (NAAG) and glutamate carboxypeptidase II: An abundant peptide neurotransmitter-enzyme system with multiple clinical applications. Prog Neurobiol. 2020;184:101722.","journal-title":"Prog Neurobiol"},{"key":"2057_CR114","volume":"7","author":"Y Wang","year":"2017","unstructured":"Wang Y, Hall RA, Lee M, Kamgar-Parsi A, Bi X, Baudry M. The tyrosine phosphatase PTPN13\/FAP-1 links calpain-2, TBI and tau tyrosine phosphorylation. Sci Rep. 2017;7:11771.","journal-title":"Sci Rep"},{"key":"2057_CR115","doi-asserted-by":"crossref","first-page":"eaba5547","DOI":"10.1126\/sciadv.aba5547","volume":"6","author":"Y Wang","year":"2020","unstructured":"Wang Y, Liu Y, Nham A, Sherbaf A, Quach D, Yahya E, et al. Calpain-2 as a therapeutic target in repeated concussion-induced neuropathy and behavioral impairment. Sci Adv. 2020;6:eaba5547.","journal-title":"Sci Adv"},{"key":"2057_CR116","doi-asserted-by":"crossref","first-page":"190","DOI":"10.3389\/fneur.2013.00190","volume":"4","author":"R Siman","year":"2013","unstructured":"Siman R, Giovannone N, Hanten G, Wilde EA, McCauley SR, Hunter JV, et al. Evidence That the Blood Biomarker SNTF Predicts Brain Imaging Changes and Persistent Cognitive Dysfunction in Mild TBI Patients. Front Neurol. 2013;4:190.","journal-title":"Front Neurol"},{"key":"2057_CR117","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/bs.apha.2016.01.007","volume":"76","author":"JJ Vornov","year":"2016","unstructured":"Vornov JJ, Hollinger KR, Jackson PF, Wozniak KM, Farah MH, Majer P, et al. Still NAAG\u2019ing After All These Years: The Continuing Pursuit of GCPII Inhibitors. Adv Pharm. 2016;76:215\u201355.","journal-title":"Adv Pharm"},{"key":"2057_CR118","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/0014-2999(95)00265-M","volume":"282","author":"R Urban","year":"1995","unstructured":"Urban R, Szabo B, Starke K. Involvement of peripheral presynaptic inhibition in the reduction of sympathetic tone by moxonidine, rilmenidine and UK 14304. Eur J Pharm. 1995;282:29\u201337.","journal-title":"Eur J Pharm"},{"key":"2057_CR119","first-page":"47","volume":"16","author":"DC U\u2019Prichard","year":"1979","unstructured":"U\u2019Prichard DC, Bechtel WD, Rouot BM, Snyder SH. Multiple apparent alpha-noradrenergic receptor binding sites in rat brain: effect of 6-hydroxydopamine. Mol Pharm. 1979;16:47\u201360.","journal-title":"Mol Pharm"},{"key":"2057_CR120","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1126\/science.2999977","volume":"230","author":"AFT Arnsten","year":"1985","unstructured":"Arnsten AFT, Goldman-Rakic PS. Alpha-2 adrenergic mechanisms in prefrontal cortex associated with cognitive decline in aged nonhuman primates. Science. 1985;230:1273\u20136.","journal-title":"Science"},{"key":"2057_CR121","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/0014-2999(91)90299-6","volume":"202","author":"S Uhlen","year":"1991","unstructured":"Uhlen S, Wikberg JES. Delineation of rat kidney alpha 2A and alpha 2B-adrenoceptors with [3H]RX821002 radioligand binding: computer modeling reveals that guanfacine is an alpha-2A-selective compound. Eur J Pharm. 1991;202:235\u201343.","journal-title":"Eur J Pharm"},{"key":"2057_CR122","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1111\/j.1476-5381.1992.tb14446.x","volume":"106","author":"S Uhlen","year":"1992","unstructured":"Uhlen S, Xia Y, Chhajlani V, Felder CC, Wikberg JES. [3H]MK912 binding delineates 2 a-2-adrenoceptor subtypes in rat CNS one of which is identical with the cloned pA2d a-2- adrenoceptor. Br J Pharm. 1992;106:986\u201395.","journal-title":"Br J Pharm"},{"key":"2057_CR123","doi-asserted-by":"crossref","first-page":"4287","DOI":"10.1523\/JNEUROSCI.08-11-04287.1988","volume":"8","author":"AFT Arnsten","year":"1988","unstructured":"Arnsten AFT, Cai JX, Goldman-Rakic PS. The alpha-2 adrenergic agonist guanfacine improves memory in aged monkeys without sedative or hypotensive side effects. J Neurosci. 1988;8:4287\u201398.","journal-title":"J Neurosci"},{"key":"2057_CR124","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1016\/S0006-3223(99)00139-0","volume":"46","author":"Z-M Mao","year":"1999","unstructured":"Mao Z-M, Arnsten AFT, Li B-M. Local infusion of alpha-1 adrenergic agonist into the prefrontal cortex impairs spatial working memory performance in monkeys. Biol Psychiatry. 1999;46:1259\u201365.","journal-title":"Biol Psychiatry"},{"key":"2057_CR125","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.brainres.2004.07.062","volume":"1024","author":"M Wang","year":"2004","unstructured":"Wang M, Tang ZX, Li BM. Enhanced visuomotor associative learning following stimulation of alpha 2A-adrenoceptors in the ventral prefrontal cortex in monkeys. Brain Res. 2004;1024:176\u201382.","journal-title":"Brain Res"},{"key":"2057_CR126","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1101\/lm.298006","volume":"13","author":"B Ramos","year":"2006","unstructured":"Ramos B, Stark D, Verduzco L, van Dyck CH, Arnsten AFT. Alpha-2A-adrenoceptor stimulation improves prefrontal cortical regulation of behavior through inhibition of cAMP signaling in aging animals. Learn Mem. 2006;13:770\u20136.","journal-title":"Learn Mem"},{"key":"2057_CR127","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/BF02245302","volume":"108","author":"AFT Arnsten","year":"1992","unstructured":"Arnsten AFT, Contant TA. Alpha-2 adrenergic agonists decrease distractability in aged monkeys performing a delayed response task. Psychopharmacology. 1992;108:159\u201369.","journal-title":"Psychopharmacology"},{"key":"2057_CR128","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1001\/archpsyc.1996.01830050084013","volume":"53","author":"AFT Arnsten","year":"1996","unstructured":"Arnsten AFT, Steere JC, Hunt RD. The contribution of alpha-2 noradrenergic mechanisms to prefrontal cortical cognitive function: potential significance to Attention Deficit Hyperactivity Disorder. Arch Gen Psychiatry. 1996;53:448\u201355.","journal-title":"Arch Gen Psychiatry"},{"key":"2057_CR129","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1037\/0735-7044.111.5.883","volume":"111","author":"JC Steere","year":"1997","unstructured":"Steere JC, Arnsten AFT. The alpha-2A noradrenergic agonist, guanfacine, improves visual object discrimination reversal performance in rhesus monkeys. Behav Neurosci. 1997;111:1\u20139.","journal-title":"Behav Neurosci"},{"key":"2057_CR130","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1007\/s002130050533","volume":"136","author":"JCS Franowicz","year":"1998","unstructured":"Franowicz JCS, Arnsten AFT. The alpha-2A noradrenergic agonist, guanfacine, improves delayed response performance in young adult rhesus monkeys. Psychopharmacology. 1998;136:8\u201314.","journal-title":"Psychopharmacology"},{"key":"2057_CR131","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/S0024-3205(00)00681-0","volume":"67","author":"J O\u2019Neill","year":"2000","unstructured":"O\u2019Neill J, Fitten LJ, Siembieda DW, Ortiz F, Halgren E. Effects of guanfacine on three forms of distraction in the aging macaque. Life Sci. 2000;67:877\u201385.","journal-title":"Life Sci"},{"key":"2057_CR132","first-page":"419","volume":"50","author":"JDJ Macy","year":"2000","unstructured":"Macy JDJ, Beattie TA, Morgenstern SE, Arnsten AF. Use of guanfacine to control self-injurious behavior in two rhesus macaques (Macaca mulatta) and one baboon (Papio anubis). Comp Med. 2000;50:419\u201325.","journal-title":"Comp Med"},{"key":"2057_CR133","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1038\/sj.npp.1300278","volume":"29","author":"M Wang","year":"2004","unstructured":"Wang M, Ji JZ, Li BM. The alpha(2A)-adrenergic agonist guanfacine improves visuomotor associative learning in monkeys. Neuropsychopharmacology. 2004;29:86\u201392.","journal-title":"Neuropsychopharmacology"},{"key":"2057_CR134","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/S0893-133X(00)00111-1","volume":"23","author":"RA Avery","year":"2000","unstructured":"Avery RA, Franowicz JS, Studholme C, van Dyck CH, Arnsten AFT. The alpha-2A-adenoceptor agonist, guanfacine, increases regional cerebral blood flow in dorsolateral prefrontal cortex of monkeys performing a spatial working memory task. Neuropsychopharmacology. 2000;23:240\u20139.","journal-title":"Neuropsychopharmacology"},{"key":"2057_CR135","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/0006-8993(84)90351-2","volume":"306","author":"AFT Arnsten","year":"1984","unstructured":"Arnsten AFT, Goldman-Rakic PS. Selective prefrontal cortical projections to the region of the locus coeruleus and raphe nuclei in the rhesus monkey. Brain Res. 1984;306:9\u201318.","journal-title":"Brain Res"},{"key":"2057_CR136","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.bbrc.2019.09.038","volume":"519","author":"Z Wu","year":"2019","unstructured":"Wu Z, Wang T, Li L, Hui Y, Zhang Q, Yuan H. Activation and blockade of \u03b12-adrenoceptors in the prelimbic cortex regulate anxiety-like behaviors in hemiparkinsonian rats. Biochem Biophys Res Commun. 2019;519:697\u2013704.","journal-title":"Biochem Biophys Res Commun"},{"key":"2057_CR137","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/S0091-3057(00)00306-3","volume":"67","author":"SG Birnbaum","year":"2000","unstructured":"Birnbaum SG, Podell DM, Arnsten AFT. Noradrenergic alpha-2 receptor agonists reverse working memory deficits induced by the anxiogenic drug, FG7142, in rats. Pharm Biochem Behav. 2000;67:397\u2013403.","journal-title":"Pharm Biochem Behav"},{"key":"2057_CR138","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ynstr.2015.01.001","volume":"2","author":"AB Hains","year":"2015","unstructured":"Hains AB, Yabe Y, Arnsten AFT. Chronic stimulation of alpha-2A-adrenoceptors with guanfacine protects rodent prefrontal cortex dendritic spines and cognition from the effects of chronic stress. Neurobiol Stress. 2015;2:1\u20139.","journal-title":"Neurobiol Stress"},{"key":"2057_CR139","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.ejphar.2004.11.044","volume":"507","author":"J Schweimer","year":"2005","unstructured":"Schweimer J, Fendt M, Schnitzler HU. Effects of clonidine injections into the bed nucleus of the stria terminalis on fear and anxiety behavior in rats. Eur J Pharm. 2005;507:117\u201324.","journal-title":"Eur J Pharm"},{"key":"2057_CR140","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1046\/j.1460-9568.2003.02544.x","volume":"17","author":"F DeBock","year":"2003","unstructured":"DeBock F, Kurz J, Azad SC, Parsons CG, Hapfelmeier G, Zieglgansberger W, et al. Alpha2-adrenoreceptor activation inhibits LTP and LTD in the basolateral amygdala: involvement of Gi\/o-protein-mediated modulation of Ca2+-channels and inwardly rectifying K+-channels in LTD. Eur J Neurosci. 2003;17:1411\u201324.","journal-title":"Eur J Neurosci"},{"key":"2057_CR141","doi-asserted-by":"crossref","first-page":"9319","DOI":"10.1523\/JNEUROSCI.0822-14.2014","volume":"34","author":"SA Flavin","year":"2014","unstructured":"Flavin SA, Matthews RT, Wang Q, Muly EC, Winder DG. \u03b1(2A)-adrenergic receptors filter parabrachial inputs to the bed nucleus of the stria terminalis. J Neurosci. 2014;34:9319\u201331.","journal-title":"J Neurosci"},{"key":"2057_CR142","doi-asserted-by":"crossref","first-page":"2118","DOI":"10.1038\/s41386-018-0024-x","volume":"43","author":"YS Mineur","year":"2018","unstructured":"Mineur YS, Cahuzac EL, Mose TN, Bentham MP, Plantenga ME, Thompson DC, et al. Interaction between noradrenergic and cholinergic signaling in amygdala regulates anxiety- and depression-related behaviors in mice. Neuropsychopharmacology. 2018;43:2118\u201325.","journal-title":"Neuropsychopharmacology"},{"key":"2057_CR143","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/S1054-3589(08)60863-7","volume":"42","author":"RJ Valentino","year":"1998","unstructured":"Valentino RJ, Curtis AL, Page ME, Pavcovich LA, Florin-Lechner SM. Activation of the locus coeruleus brain noradrenergic system during stress: Circuitry, consequences, and regulation. Adv Pharm. 1998;42:781\u20134.","journal-title":"Adv Pharm"},{"key":"2057_CR144","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/0014-2999(77)90312-0","volume":"44","author":"JM Cedarbaum","year":"1977","unstructured":"Cedarbaum JM, Aghajanian GK. Catecholamine receptors on locus coeruleus neurons: pharmacological characterization. Eur J Pharm. 1977;44:375\u201385.","journal-title":"Eur J Pharm"},{"key":"2057_CR145","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/0091-3057(91)90166-Y","volume":"39","author":"Y Ida","year":"1991","unstructured":"Ida Y, Elsworth J, Roth RH. Anxiogenic beta carboline FG7142 produces activation of NE neurons in specific brain regions of rats. Pharm Biochem Behav. 1991;39:791\u20133.","journal-title":"Pharm Biochem Behav"},{"key":"2057_CR146","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.brainres.2004.08.057","volume":"1027","author":"BA Morrow","year":"2004","unstructured":"Morrow BA, George TP, Roth RH. Noradrenergic alpha-2 agonists have anxiolytic-like actions on stress-related behavior and mesoprefrontal dopamine biochemistry. Brain Res. 2004;1027:173\u20138.","journal-title":"Brain Res"},{"key":"2057_CR147","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.neuron.2005.09.025","volume":"48","author":"EA Phelps","year":"2005","unstructured":"Phelps EA, LeDoux JE. Contributions of the amygdala to emotion processing: from animal models to human behavior. Neuron. 2005;48:175\u201387.","journal-title":"Neuron"},{"key":"2057_CR148","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1037\/a0026187","volume":"125","author":"B Roozendaal","year":"2011","unstructured":"Roozendaal B, McGaugh JL. Memory modulation. Behav Neurosci. 2011;125:797\u2013824.","journal-title":"Behav Neurosci"},{"key":"2057_CR149","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1007\/BF00169548","volume":"343","author":"G Engberg","year":"1991","unstructured":"Engberg G, Eriksson E. Effects of alpha-2-adrenoceptor agonists on locus coeruleus firing rate and brain noradrenaline turnover in EEDQ-treated rats. Naunyn-Schmiedebergs Arch Pharm. 1991;343:472\u20137.","journal-title":"Naunyn-Schmiedebergs Arch Pharm"},{"key":"2057_CR150","doi-asserted-by":"crossref","first-page":"4122","DOI":"10.3390\/ijms22084122","volume":"22","author":"K Fukuyama","year":"2021","unstructured":"Fukuyama K, Nakano T, Shiroyama T, Okada M. Chronic Administrations of Guanfacine on Mesocortical Catecholaminergic and Thalamocortical Glutamatergic Transmissions. Int J Mol Sci. 2021;22:4122.","journal-title":"Int J Mol Sci"},{"key":"2057_CR151","doi-asserted-by":"crossref","first-page":"e57670","DOI":"10.7554\/eLife.57670","volume":"9","author":"JJ Ballesteros","year":"2020","unstructured":"Ballesteros JJ, Briscoe JB, Ishizawa Y. Neural signatures of \u03b12-Adrenergic agonist-induced unconsciousness and awakening by antagonist. Elife. 2020;9:e57670.","journal-title":"Elife"},{"key":"2057_CR152","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1097\/00000542-200302000-00024","volume":"98","author":"LE Nelson","year":"2003","unstructured":"Nelson LE, Lu J, Guo T, Saper CB, Franks NP, Maze M. The alpha2-adrenoceptor agonist dexmedetomidine converges on an endogenous sleep-promoting pathway to exert its sedative effects. Anesthesiology. 2003;98:428\u201336.","journal-title":"Anesthesiology"},{"key":"2057_CR153","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0014-2999(99)00306-4","volume":"374","author":"CC Jansson","year":"1999","unstructured":"Jansson CC, Pohjanoksa K, Lang J, Wurster S, Savola JM, Scheinin M. Alpha2-adrenoceptor agonists stimulate high-affinity GTPase activity in a receptor subtype-selective manner. Eur J Pharm. 1999;374:137\u201346.","journal-title":"Eur J Pharm"},{"key":"2057_CR154","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1111\/j.1460-9568.1991.tb00083.x","volume":"3","author":"G Buzsaki","year":"1991","unstructured":"Buzsaki G, Kennedy B, Solt VB, Ziegler M. Noradrenergic control of thalamic oscillation: The role of alpha-2 receptors. Eur J Neuro. 1991;3:222\u20139.","journal-title":"Eur J Neuro"},{"key":"2057_CR155","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1002\/cne.903280409","volume":"328","author":"AP Nicholas","year":"1993","unstructured":"Nicholas AP, Pieribone V, H\u00f6kfelt T. Distributions of mRNAs for alpha-2 adrenergic receptor subtypes in rat brain: an in situ hybridization study. J Comp Neurol. 1993;328:575\u201394.","journal-title":"J Comp Neurol"},{"key":"2057_CR156","first-page":"241","volume":"46","author":"E MacDonald","year":"1995","unstructured":"MacDonald E, Scheinin M. Distribution and pharmacology of alpha 2-adrenoceptors in the central nervous system. J Physiol Pharm. 1995;46:241\u201358.","journal-title":"J Physiol Pharm"},{"key":"2057_CR157","doi-asserted-by":"crossref","first-page":"330","DOI":"10.3389\/fnins.2020.00330","volume":"14","author":"Y Zhao","year":"2020","unstructured":"Zhao Y, He J, Yu N, Jia C, Wang S. Mechanisms of Dexmedetomidine in Neuropathic Pain. Front Neurosci. 2020;14:330.","journal-title":"Front Neurosci"},{"key":"2057_CR158","doi-asserted-by":"crossref","first-page":"2366","DOI":"10.1111\/bph.14580","volume":"176","author":"Z Bahari","year":"2019","unstructured":"Bahari Z, Meftahi GH. Spinal \u03b12 -adrenoceptors and neuropathic pain modulation; therapeutic target. Br J Pharm. 2019;176:2366\u201381.","journal-title":"Br J Pharm"},{"key":"2057_CR159","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1016\/j.bbrc.2019.11.146","volume":"522","author":"BM Lee","year":"2020","unstructured":"Lee BM, Jang Y, Park G, Kim K, Oh SH, Shin TJ, et al. Dexmedetomidine modulates transient receptor potential vanilloid subtype 1. Biochem Biophys Res Commun. 2020;522:832\u20137.","journal-title":"Biochem Biophys Res Commun"},{"key":"2057_CR160","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/cns.13774","volume":"28","author":"JW Hao","year":"2022","unstructured":"Hao JW, Qiao WL, Li Q, Wei S, Liu TT, Qiu CY, et al. Suppression of P2X3 receptor-mediated currents by the activation of \u03b12A -adrenergic receptors in rat dorsal root ganglion neurons. CNS Neurosci Ther. 2022;28:289\u201397.","journal-title":"CNS Neurosci Ther"},{"key":"2057_CR161","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.ejphar.2016.02.046","volume":"776","author":"HS Farghaly","year":"2016","unstructured":"Farghaly HS, Mahmoud AM, Abdel-Sater KA. Effect of dexmedetomidine and cold stress in a rat model of neuropathic pain: Role of interleukin-6 and tumor necrosis factor-\u03b1. Eur J Pharm. 2016;776:139\u201345.","journal-title":"Eur J Pharm"},{"key":"2057_CR162","doi-asserted-by":"crossref","first-page":"3440","DOI":"10.3390\/ijms21103440","volume":"21","author":"KK Kummer","year":"2020","unstructured":"Kummer KK, Mitri\u0107 M, Kalpachidou T, Kress M. The Medial Prefrontal Cortex as a Central Hub for Mental Comorbidities Associated with Chronic Pain. Int J Mol Sci. 2020;21:3440.","journal-title":"Int J Mol Sci"},{"key":"2057_CR163","doi-asserted-by":"crossref","first-page":"678","DOI":"10.3389\/fphar.2020.00678","volume":"11","author":"W Zhang","year":"2020","unstructured":"Zhang W, Wang TJ, Wang G, Yang M, Zhou Y, Yuan Y. Effects of Dexmedetomidine on Postoperative Delirium and Expression of IL-1\u03b2, IL-6, and TNF-\u03b1 in Elderly Patients After Hip Fracture Operation. Front Pharm. 2020;11:678.","journal-title":"Front Pharm"},{"key":"2057_CR164","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1007\/s40268-021-00368-x","volume":"21","author":"R Chen","year":"2021","unstructured":"Chen R, Kang Z, Wang Y, Zhao J, Li S. The Anti-inflammatory Effect of Dexmedetomidine Administration on Patients Undergoing Intestinal Surgery: A Randomized Study. Drugs R D. 2021;21:445\u201353.","journal-title":"Drugs R D"},{"key":"2057_CR165","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1111\/bph.15363","volume":"178","author":"YR Lankadeva","year":"2021","unstructured":"Lankadeva YR, Shehabi Y, Deane AM, Plummer MP, Bellomo R, May CN. Emerging benefits and drawbacks of \u03b12 -adrenoceptor agonists in the management of sepsis and critical illness. Br J Pharm. 2021;178:1407\u201325.","journal-title":"Br J Pharm"},{"key":"2057_CR166","first-page":"1345695","volume":"2022","author":"M Ding","year":"2022","unstructured":"Ding M, Xu X, Xia L, Cao Y. Magnetic Resonance Imaging Characteristic Evaluation of Dexmedetomidine on Neurocognitive Dysfunction in Elderly Patients with Colorectal Tumors after Laparoscopic Operation. Comput Math Methods Med. 2022;2022:1345695.","journal-title":"Comput Math Methods Med"},{"key":"2057_CR167","doi-asserted-by":"crossref","first-page":"171","DOI":"10.3389\/fphar.2015.00171","volume":"6","author":"A Scanzano","year":"2015","unstructured":"Scanzano A, Cosentino M. Adrenergic regulation of innate immunity: a review. Front Pharm. 2015;6:171.","journal-title":"Front Pharm"},{"key":"2057_CR168","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.jss.2012.07.017","volume":"181","author":"Y Chang","year":"2013","unstructured":"Chang Y, Huang X, Liu Z, Han G, Huang L, Xiong YC, et al. Dexmedetomidine inhibits the secretion of high mobility group box 1 from lipopolysaccharide-activated macrophages in vitro. J Surg Res. 2013;181:308\u201314.","journal-title":"J Surg Res"},{"key":"2057_CR169","doi-asserted-by":"crossref","first-page":"173733","DOI":"10.1016\/j.ejphar.2020.173733","volume":"892","author":"M Fujimoto","year":"2021","unstructured":"Fujimoto M, Higuchi H, Honda-Wakasugi Y, Miyake S, Nishioka Y, Yabuki-Kawase A, et al. Dexmedetomidine inhibits LPS-induced inflammatory responses through peroxisome proliferator-activated receptor gamma (PPAR\u03b3) activation following binding to \u03b12 adrenoceptors. Eur J Pharm. 2021;892:173733.","journal-title":"Eur J Pharm"},{"key":"2057_CR170","doi-asserted-by":"crossref","first-page":"15291","DOI":"10.1074\/jbc.M113.458901","volume":"288","author":"S Gyoneva","year":"2013","unstructured":"Gyoneva S, Traynelis SF. Norepinephrine modulates the motility of resting and activated microglia via different adrenergic receptors. J Biol Chem. 2013;288:15291\u2013302.","journal-title":"J Biol Chem"},{"key":"2057_CR171","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1213\/ANE.0000000000005699","volume":"134","author":"N Kii","year":"2022","unstructured":"Kii N, Sawada A, Yoshikawa Y, Tachibana S, Yamakage M. Dexmedetomidine Ameliorates Perioperative Neurocognitive Disorders by Suppressing Monocyte-Derived Macrophages in Mice With Preexisting Traumatic Brain Injury. Anesth Analg. 2022;134:869\u201380.","journal-title":"Anesth Analg"},{"key":"2057_CR172","doi-asserted-by":"crossref","first-page":"661","DOI":"10.3892\/mmr.2021.12300","volume":"24","author":"X Feng","year":"2021","unstructured":"Feng X, Ma W, Zhu J, Jiao W, Wang Y. Dexmedetomidine alleviates early brain injury following traumatic brain injury by inhibiting autophagy and neuroinflammation through the ROS\/Nrf2 signaling pathway. Mol Med Rep. 2021;24:661.","journal-title":"Mol Med Rep"},{"key":"2057_CR173","doi-asserted-by":"crossref","first-page":"2594","DOI":"10.3390\/cells9122594","volume":"9","author":"Y Ruan","year":"2020","unstructured":"Ruan Y, B\u00f6hmer T, Jiang S, Gericke A. The role of adrenoceptors in the retina. Cells. 2020;9:2594.","journal-title":"Cells"},{"key":"2057_CR174","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.2147\/DDDT.S221126","volume":"15","author":"T Ota","year":"2021","unstructured":"Ota T, Yamamuro K, Okazaki K, Kishimoto T. Evaluating Guanfacine Hydrochloride in the Treatment of Attention Deficit Hyperactivity Disorder (ADHD) in Adult Patients: Design, Development and Place in Therapy. Drug Des Devel Ther. 2021;15:1965\u20139.","journal-title":"Drug Des Devel Ther"},{"key":"2057_CR175","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1089\/cap.2012.0119","volume":"23","author":"DF Connor","year":"2013","unstructured":"Connor DF, Grasso DJ, Slivinsky MD, Pearson GS, Banga A. An open-label study of guanfacine extended release for traumatic stress related symptoms in children and adolescents. J Child Adolesc Psychopharmacol. 2013;23:244\u201351.","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"2057_CR176","first-page":"755","volume":"24","author":"DF Connor","year":"2010","unstructured":"Connor DF, Findling RL, Kollins SH, Sallee F, L\u00f3pez FA, Lyne A, et al. Effects of guanfacine extended release on oppositional symptoms in children aged 6-12 years with attention-deficit hyperactivity disorder and oppositional symptoms: a randomized, double-blind, placebo-controlled trial. CNS Drugs. 2010;24:755\u201368.","journal-title":"CNS Drugs"},{"key":"2057_CR177","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1089\/cap.2009.0059","volume":"20","author":"JT McCracken","year":"2010","unstructured":"McCracken JT, Aman MG, McDougle CJ, Tierney E, Shiraga S, Whelan F, et al. Possible influence of variant of the P-glycoprotein gene (MDR1\/ABCB1) on clinical response to guanfacine in children with pervasive developmental disorders and hyperactivity. J Child Adolesc Psychopharmacol. 2010;20:1\u20135. PMCID: PMC2835389","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"2057_CR178","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1038\/s41386-018-0039-3","volume":"43","author":"LC Politte","year":"2018","unstructured":"Politte LC, Scahill L, Figueroa J, McCracken JT, King B, McDougle CJ. A randomized, placebo-controlled trial of extended-release guanfacine in children with autism spectrum disorder and ADHD symptoms: an analysis of secondary outcome measures. Neuropsychopharmacology. 2018;43:1772\u20138.","journal-title":"Neuropsychopharmacology"},{"key":"2057_CR179","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1089\/cap.2018.0102","volume":"29","author":"D Singh","year":"2019","unstructured":"Singh D, Wakimoto Y, Filangieri C, Pinkhasov A, Angulo M. Guanfacine Extended Release for the Reduction of Aggression, Attention-Deficit\/Hyperactivity Disorder Symptoms, and Self-Injurious Behavior in Prader-Willi Syndrome-A Retrospective Cohort Study. J Child Adolesc Psychopharmacol. 2019;29:313\u20137.","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"2057_CR180","doi-asserted-by":"crossref","DOI":"10.1038\/tp.2015.61","volume":"5","author":"ZT Freeman","year":"2015","unstructured":"Freeman ZT, Rice KA, Soto PL, Pate KA, Weed MR, Ator NA, et al. Neurocognitive dysfunction and pharmacological intervention using guanfacine in a rhesus macaque model of self-injurious behavior. Transl Psychiatry. 2015;5:e567.","journal-title":"Transl Psychiatry"},{"key":"2057_CR181","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.ijpsycho.2011.06.022","volume":"82","author":"TW McAllister","year":"2011","unstructured":"McAllister TW, McDonald BC, Flashman LA, Ferrell RB, Tosteson TD, Yanofsky NN, et al. Alpha-2 adrenergic challenge with guanfacine one month after mild traumatic brain injury: Altered working memory and BOLD response. Int J Psychophysiol. 2011;82:107\u201314.","journal-title":"Int J Psychophysiol"},{"key":"2057_CR182","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1002\/ana.20701","volume":"59","author":"PA Malhotra","year":"2006","unstructured":"Malhotra PA, Parton AD, Greenwood R, Husain M. Noradrenergic modulation of space exploration in visual neglect. Ann Neurol. 2006;59:186\u201390.","journal-title":"Ann Neurol"},{"key":"2057_CR183","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1136\/jnnp-2017-317338","volume":"89","author":"ES Dalmaijer","year":"2018","unstructured":"Dalmaijer ES, Li KMS, Gorgoraptis N, Leff AP, Cohen DL, Parton AD, et al. Randomised, double-blind, placebo-controlled crossover study of single-dose guanfacine in unilateral neglect following stroke. J Neurol Neurosurg Psychiatry. 2018;89:593\u20138.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2057_CR184","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1136\/jnnp.2009.195792","volume":"82","author":"V Singh-Curry","year":"2011","unstructured":"Singh-Curry V, Malhotra P, Farmer SF, Husain M. Attention deficits following ADEM ameliorated by guanfacine. J Neurol Neurosurg Psychiatry. 2011;82:688\u201390.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2057_CR185","doi-asserted-by":"crossref","first-page":"100154","DOI":"10.1016\/j.nerep.2022.100154","volume":"3","author":"A Fesharaki-Zadeh","year":"2023","unstructured":"Fesharaki-Zadeh A, Lowe N, Arnsten AFT. Clinical experience with the \u03b12A-adrenoceptor agonist, guanfacine, and N-acetylcysteine for the treatment of cognitive deficits in \u201cLong-COVID19\u201d. Neuroimmunol Rep. 2023;3:100154.","journal-title":"Neuroimmunol Rep"},{"key":"2057_CR186","doi-asserted-by":"crossref","DOI":"10.1186\/s13063-022-06190-3","volume":"23","author":"K Hoang","year":"2022","unstructured":"Hoang K, Watt H, Golemme M, Perry RJ, Ritchie C, Wilson D, et al. Noradrenergic Add-on Therapy with Extended-Release Guanfacine in Alzheimer\u2019s Disease (NorAD): study protocol for a randomised clinical trial and COVID-19 amendments. Trials. 2022;23:623.","journal-title":"Trials"},{"key":"2057_CR187","doi-asserted-by":"crossref","first-page":"2644","DOI":"10.1001\/jama.298.22.2644","volume":"298","author":"PP Pandharipande","year":"2007","unstructured":"Pandharipande PP, Pun BT, Herr DL, Maze M, Girard TD, Miller RR, et al. Effect of sedation with dexmedetomidine vs lorazepam on acute brain dysfunction in mechanically ventilated patients: the MENDS randomized controlled trial. JAMA. 2007;298:2644\u201353.","journal-title":"JAMA"},{"key":"2057_CR188","first-page":"131","volume":"120","author":"SC Bauer","year":"2021","unstructured":"Bauer SC, Moral F, Preloger E, Spindler A, Roman M, Logan A, et al. Pediatric COVID-19 Delirium: Case Report of 2 Adolescents. WMJ. 2021;120:131\u20136.","journal-title":"WMJ"},{"key":"2057_CR189","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1177\/1089253218768537","volume":"22","author":"H Srour","year":"2018","unstructured":"Srour H, Pandya K, Flannery A, Hatton K. Enteral Guanfacine to Treat Severe Anxiety and Agitation Complicating Critical Care After Cardiac Surgery. Semin Cardiothorac Vasc Anesth. 2018;22:403\u20136.","journal-title":"Semin Cardiothorac Vasc Anesth"},{"key":"2057_CR190","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/j.psym.2020.05.007","volume":"61","author":"Y Sher","year":"2020","unstructured":"Sher Y, Rabkin B, Maldonado JR, Mohabir P. COVID-19-Associated Hyperactive Intensive Care Unit Delirium With Proposed Pathophysiology and Treatment: A Case Report. Psychosomatics. 2020;61:544\u201350.","journal-title":"Psychosomatics"},{"key":"2057_CR191","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.psym.2020.10.003","volume":"62","author":"S Jiang","year":"2021","unstructured":"Jiang S, Czuma R, Cohen-Oram A, Hartney K, Stern TA. Guanfacine for Hyperactive Delirium: A Case Series. J Acad Consult Liaison Psychiatry. 2021;62:83\u201388.","journal-title":"J Acad Consult Liaison Psychiatry"}],"container-title":["Molecular Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41380-023-02057-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41380-023-02057-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41380-023-02057-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,8]],"date-time":"2024-03-08T16:25:47Z","timestamp":1709915147000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41380-023-02057-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,7]]},"references-count":191,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2023,11]]}},"alternative-id":["2057"],"URL":"https:\/\/doi.org\/10.1038\/s41380-023-02057-4","relation":{},"ISSN":["1359-4184","1476-5578"],"issn-type":[{"value":"1359-4184","type":"print"},{"value":"1476-5578","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,7]]},"assertion":[{"value":"20 November 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 March 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 March 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 April 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}